
Veeva Systems VEEV
$ 172.28
1.2%
Annual report 2026
added 03-20-2026
Veeva Systems DPO Ratio 2011-2026 | VEEV
Annual DPO Ratio Veeva Systems
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.9 | 16.2 | 19.7 | 18.6 | 15.8 | 19 | 23.4 | 13.6 | 12 | 11.9 | 11.8 | 12.3 | 9.35 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.4 | 9.35 | 15.3 |
Quarterly DPO Ratio Veeva Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.2 | 16.6 | 18.2 | - | - | - | 23.4 | 25.5 | 17.7 | - | 21.3 | 16.9 | 15.9 | - | 16.5 | 15 | 15 | - | 16.7 | 14.8 | 11.6 | - | 11.5 | 11 | 10.7 | - | 13.8 | 12.8 | 11.2 | - | 11.8 | 10.4 | 9.11 | - | 11.9 | 11.9 | 9.46 | 16.2 | 13.7 | 12.5 | 10.6 | 7.99 | 5.92 | 7.94 | 11.3 | 15.7 | 5.2 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25.5 | 5.2 | 13.6 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M | ||
|
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B | ||
|
HealthEquity
HQY
|
12.1 | $ 81.57 | -0.74 % | $ 7.03 B | ||
|
Computer Programs and Systems
CPSI
|
17.8 | - | 4.4 % | $ 133 M | ||
|
iCAD
ICAD
|
112 | - | - | $ 102 M | ||
|
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | ||
|
Akerna Corp.
KERN
|
5.62 | - | - | $ 161 M | ||
|
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | ||
|
Evolent Health
EVH
|
27 | $ 3.88 | -2.63 % | $ 364 M | ||
|
GoodRx Holdings
GDRX
|
191 | $ 2.45 | -2.0 % | $ 945 M | ||
|
10x Genomics
TXG
|
32.5 | $ 22.11 | 2.1 % | $ 2.59 B | ||
|
Allscripts Healthcare Solutions
MDRX
|
10.9 | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | ||
|
1Life Healthcare
ONEM
|
18 | - | - | $ 3.37 B | ||
|
Premier
PINC
|
28.6 | - | - | $ 2.33 B | ||
|
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | ||
|
Health Catalyst
HCAT
|
23.8 | $ 1.58 | 0.32 % | $ 110 M | ||
|
OptimizeRx Corporation
OPRX
|
24.1 | $ 6.53 | -3.55 % | $ 112 M | ||
|
Schrödinger
SDGR
|
35.6 | $ 13.01 | 0.85 % | $ 955 M | ||
|
Phreesia
PHR
|
43.7 | $ 9.55 | -1.24 % | $ 570 M | ||
|
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | ||
|
Teladoc Health
TDOC
|
19.2 | $ 6.75 | 1.73 % | $ 1.19 B | ||
|
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | ||
|
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | ||
|
SCWorx Corp.
WORX
|
43.2 | - | - | $ 7.71 M | ||
|
American Well Corporation
AMWL
|
10.4 | $ 6.43 | -0.31 % | $ 103 M | ||
|
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | ||
|
HealthStream
HSTM
|
26.3 | $ 22.68 | 6.73 % | $ 689 M | ||
|
Omnicell
OMCL
|
27.6 | $ 44.11 | 1.54 % | $ 2.03 B | ||
|
Progyny
PGNY
|
171 | $ 18.91 | - | $ 1.62 B | ||
|
Zhongchao
ZCMD
|
31 | $ 2.2 | -0.9 % | $ 7.52 M |